EUVIMEDEUVIMED entdecken
Crossref

Silibinin’s role in counteracting neuronal apoptosis and synaptic dysfunction in Alzheimer’s disease models

Baohui Zhang, Di Zhang, Keyan Chen, Tengfei Wu

Apoptosis · 2025

DOI: 10.1007/s10495-024-02073-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2025. Verfasst von Baohui Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, China Medical University, Shenyang, 110122, China. Hauptthemen laut MEDLINE: Silybin, Alzheimer Disease, Apoptosis, Neurons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: the Liaoning Provincial Natural Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates silibinin's capacity to mitigate Alzheimer's disease (AD) pathologies with a particular emphasis on its effects on apoptosis and synaptic dysfunction in AD models. Employing APP/PS1 transgenic mice and SH-SY5Y neuroblastoma cell lines, our research assessed the efficacy of silibinin in reducing amyloid-beta (Aβ) deposition, neuroinflammation, and neuronal apoptosis. Our results demonstrate that silibinin significantly decreases Aβ accumulation and neuroinflammation and robustly inhibits apoptosis in neuronal cells. Additionally, silibinin enhances the expression of synaptic proteins, thereby supporting synaptic integrity. Through network pharmacology analysis, we identified potential targets of silibinin in Aβ metabolism and synaptic functions. Mechanistically, our findings suggest that silibinin promotes neuronal survival predominantly via the modulation of the Fyn/GluN2B/CaMKIIα signaling pathway, which protects against Aβ1-42-induced apoptosis. These insights highlight silibinin's potential as a therapeutic agent for AD, particularly its role in reducing neuronal apoptosis and maintaining synaptic function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SilybinAlzheimer DiseaseApoptosisNeuronsSynapsesAnimalsHumansAmyloid beta-PeptidesMiceMice, TransgenicDisease Models, AnimalCell Line, TumorSignal TransductionAmyloid beta-Protein Precursor

Stichwörter der Autor:innen

Alzheimer's diseaseAβ depositionFyn/GluN2B/CaMKIIα signaling pathwayNeuroprotectionSilibininSynaptic dysfunction

Substanzen

SilybinAmyloid beta-PeptidesAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Department of Neurobiology, China Medical University, Shenyang, 110122, China.
  • Journal Center, China Medical University, Shenyang, 110122, China.
  • Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China.
  • Department of Laboratory Animal Science, China Medical University, No. 77, Puhe Road, Shenbei New District, Shenyang, Liaoning Province, 110122, China. kychen@cmu.edu.cn.
  • Department of Laboratory Animal Science, China Medical University, No. 77, Puhe Road, Shenbei New District, Shenyang, Liaoning Province, 110122, China. tfwu@cmu.edu.cn.

Förderung

  • the Liaoning Provincial Natural Fund

Zitieren

APA

Zhang, B., Zhang, D., Chen, K., & Wu, T. (2025). Silibinin’s role in counteracting neuronal apoptosis and synaptic dysfunction in Alzheimer’s disease models. Apoptosis. https://doi.org/10.1007/s10495-024-02073-x

Vancouver

Zhang B, Zhang D, Chen K, Wu T. Silibinin’s role in counteracting neuronal apoptosis and synaptic dysfunction in Alzheimer’s disease models. Apoptosis. 2025. doi:10.1007/s10495-024-02073-x

BibTeX
@article{Zhang2025,
  author = {Zhang, Baohui and Zhang, Di and Chen, Keyan and Wu, Tengfei},
  title = {Silibinin’s role in counteracting neuronal apoptosis and synaptic dysfunction in Alzheimer’s disease models},
  journal = {Apoptosis},
  year = {2025},
  doi = {10.1007/s10495-024-02073-x}
}
Kostenlos starten →